Metformin: From diabetes to cancer to prolongation of life
Open Access
- 25 August 2024
- journal article
- research article
- Published by Elsevier in Pharmacological Research
- Vol. 208, 107367
Abstract
No abstract availableKeywords
This publication has 206 references indexed in Scilit:
- Early Metformin in Gestational DiabetesJAMA, 2023
- Inflammation and vascular dysfunction: The negative synergistic combination of diabetes and COVID‐19Diabetes/Metabolism Research and Reviews, 2022
- ITC Commentary on Metformin Clinical Drug–Drug Interaction Study Design That Enables an Efficacy‐ and Safety‐Based Dose Adjustment DecisionClinical Pharmacology & Therapeutics, 2018
- Variants in Pharmacokinetic Transporters and Glycemic Response to Metformin: A Metgen Meta‐AnalysisClinical Pharmacology & Therapeutics, 2016
- Metformin use and survival after colorectal cancer: A population‐based cohort studyInternational Journal of Cancer, 2015
- Redox regulation of endothelial cell fateCellular and Molecular Life Sciences, 2014
- Metformin Decreases Food Consumption and Induces Weight Loss in Subjects with Obesity with Type II Non‐Insulin‐Dependent DiabetesObesity Research, 1998
- Prospective comparative study in NIDDM patients of metformin and glibenclamide with special reference to lipid profilesEuropean Journal of Clinical Pharmacology, 1991
- Metformin reduces post-prandial insulin needs in type I (insulin-dependent) diabetic patients: Assessment by the artificial pancreasDiabetologia, 1982
- Disposition of metformin (N,N‐dimethylbiguanide) in manClinical Pharmacology & Therapeutics, 1978